Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
about
Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated SpondyloarthritisAssociation of inflammation with raised serum IgA in ankylosing spondylitisSubpopulations of T lymphocytes in patients with ankylosing spondylitis.A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis.Immunoregulatory T cells in the peripheral blood of patients with Bechterew's syndrome.Acute-phase proteins and serum immunoglobulins in ankylosing spondylitisIgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.IgA-alpha 1 antitrypsin complexes in ankylosing spondylitis.Polyclonal B cell activation in ankylosing spondylitis.Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitisAnkylosing spondylitis and monoclonal gammopathies.Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins.IgG and IgA immune response against klebsiella in HLA-B27-associated anterior uveitis.Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathiesRole of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitisThe use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis.The role of the gut and microbes in the pathogenesis of spondyloarthritis.Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis.Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritisThe link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption.A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults.76 patients with ankylosing spondylitis seen after 30 years of disease.Urolithiasis as an extraarticular manifestation of ankylosing spondylitis.Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobinSerum IgA to enterobacteria in ankylosing spondylitis.
P2860
Q32115630-A213CA7E-43B0-4B53-BB13-1B48B504BC28Q33552748-DFED8C07-CB1A-45CB-B19A-61A1ACC26B4CQ33552775-65309169-D076-4DD1-BD4E-5DF1FA27C9B2Q33553069-9A39D7E0-AF3C-4EE6-AB80-7393EEED92BDQ33553461-51A61822-63A9-4720-A63B-C33C33F262EBQ33554711-71B1BF8E-090A-4617-8D9B-C7D7C76491ECQ33555253-7F474625-17B3-44F6-9FF2-C59506CD0177Q33557368-9866ECB8-8A12-44CB-89FB-657740217659Q33561355-71DF3C27-8DAE-4751-8F0B-FAF4A9A2948CQ33562712-B6FEDA6E-72F1-4FC9-8230-7DF87803763DQ33564743-6C8B4069-7E5A-4A7A-B14C-74B4B4D38131Q33564944-52F815E0-7AD7-459B-90BD-E5911DCD4033Q33569637-E026EDAF-EA66-4340-AD1C-6E47AB23A98AQ33645046-DC8C4C72-12FD-4FC3-882C-49E7A21DA02CQ34068253-9F235345-A244-4005-AC35-CE26AFCE1D8BQ34345584-34EBF45F-60C3-4FA2-AE3F-36F0C0D22958Q34400086-D62B1E9B-98A3-4700-B271-1C742D0C6B15Q34942393-F6E756F5-AB3B-4A79-BA5F-144051F42174Q35017147-F44ED743-8053-412D-B90C-99B24277125CQ35694939-F0194684-AA1C-4C47-B93D-F85B87AB2123Q36918422-ED0DDF4D-404E-4F90-B616-7D7E0A5BF7B5Q37335667-3699F463-BD0C-4496-8A19-C51630CE17E7Q37907401-1492AF54-CBAF-45D0-B8B1-667638BA8A9AQ38640178-BD6CE9C8-9649-4E16-A6FA-17F54EDB175DQ41233113-EA002DE5-D99F-4F49-8B39-3857CCABD72CQ41523434-47BC293A-6941-4E96-9392-9E8A29B85A66
P2860
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
description
1973 nî lūn-bûn
@nan
1973 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@ast
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@en
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@nl
type
label
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@ast
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@en
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@nl
prefLabel
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@ast
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@en
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@nl
P2860
P356
P1476
Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
@en
P2093
P2860
P304
P356
10.1136/ARD.32.6.493
P407
P577
1973-11-01T00:00:00Z